Page last updated: 2024-09-02

ecopipam and am 251

ecopipam has been researched along with am 251 in 1 studies

Compound Research Comparison

Studies (ecopipam)	Trials (ecopipam)	Recent Studies (post-2010) (ecopipam)	Studies (am 251)	Trials (am 251)	Recent Studies (post-2010) (am 251)
147	18	34	948	1	507

Protein Interaction Comparison

Protein	Taxonomy	ecopipam (IC50)	am 251 (IC50)
Cannabinoid receptor 1	Homo sapiens (human)		0.0892

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Makriyannis, A; Olszewska, T; Salamone, JD; Sink, KS; Vemuri, VK	1

Other Studies

1 other study(ies) available for ecopipam and am 251

Article	Year
Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior. Psychopharmacology, 2008, Volume: 196, Issue:4 Topics: Animals; Benzazepines; Choice Behavior; Conditioning, Operant; Dopamine Antagonists; Feeding Behavior; Food Preferences; Injections, Intraperitoneal; Male; Motivation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reinforcement Schedule; Salicylamides	2008

Article

Year

Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior.

Psychopharmacology, 2008, Volume: 196, Issue:4

Topics: Animals; Benzazepines; Choice Behavior; Conditioning, Operant; Dopamine Antagonists; Feeding Behavior; Food Preferences; Injections, Intraperitoneal; Male; Motivation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reinforcement Schedule; Salicylamides

2008